iOnctura
PrivateLast Round
Series B
Jun 20, 2024
Est. Valuation
$139.6M
Total Funding Raised
$111.26M
Company Overview
iOnctura is a biotechnology company focused on developing next-generation bio-molecules for the treatment of cancer and fibrosis through innovative therapeutics that target immunosuppression in the tumor microenvironment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iOnctura Comparables
Compare iOnctura with similar companies based on industry and business-model similarity.
iOnctura Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 20, 2024 | ||||
| Grant | Dec 20, 2022 | ||||
| Debt | Sep 28, 2022 | ||||
| Series A Extension | Jul 14, 2020 | ||||
| Series A | Jan 23, 2020 | ||||
Seed | Jun 20, 2017 |
Key People
Founding team and executive leadership
iOnctura Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council | Grant, Series B |
| XGEN Venture | Series B |
| Syncona | Series B |
| Fongit | Debt |
| 3B FUTURE Health Fund | Series B, Series A Extension |
| M Ventures | Series A, Series B |
| VI Partners | Series B, Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 9, 2026
CEO to present at the 2026 J.P. Morgan Healthcare Conference.
- Jul 1, 2025
Collaborating with Dana-Farber Cancer Institute to expand US clinical trials.
iOnctura Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about iOnctura's valuation, stock price, and market status.